Svetlana Vorona

Dr. Svetlana Vorona

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in ACS Omega
Verified
Journal Article
Open access
TGTatyana Grigoreva
Tatyana Grigoreva
Svetlana VoronaSvetlana Vorona
Svetlana Vorona
DNDaria Novikova
Daria Novikova
VTVyacheslav Tribulovich
Vyacheslav Tribulovich
P-glycoprotein (P-gp) is found to be of considerable interest for the design of drugs capable of treating chemoresistant tumors. This transporter is an interesting target for which an efficient approach has not yet been developed in terms of computer simulation. In this work, we use a combination of docking, molecular dynamics, and metadynamics to fully explore the states that occur during the capture of a ligand and subsequent efflux by P-gp. The proposed approach allowed us to substantiate a number of experimentally established facts, as well as to develop a new criterion for identifying potential P-gp inhibitors.

26 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
DNDaria Novikova
Daria Novikova
ASAleksandra Sagaidak
Aleksandra Sagaidak
Svetlana VoronaSvetlana Vorona
Svetlana Vorona
VTVyacheslav Tribulovich
Vyacheslav Tribulovich
Nucleic acid chemistry is a huge research area that has received new impetus due to the recent explosive success of oligonucleotide therapy. In order for an oligonucleotide to become clinically effective, its monomeric parts are subjected to modifications. Although a large number of redesigned natural nucleic acids have been proposed in recent years, the vast majority of them are combinations of simple modifications proposed over the past 50 years. This review is devoted to the main modifications of the sugar phosphate backbone of natural nucleic acids known to date. Here, we propose a systematization of existing knowledge about modifications of nucleic acid monomers and an acceptable classification from the point of view of chemical logic. The visual representation is intended to inspire researchers to create a new type of modification or an original combination of known modifications that will produce unique oligonucleotides with valuable characteristics.

12 September 2023 in Molecules
Verified
Journal Article
Open access
PDF file
DNDaria Novikova
Daria Novikova
AMAmmar Al Mustafa
Ammar Al Mustafa
TGTatyana Grigoreva
Tatyana Grigoreva
Svetlana VoronaSvetlana Vorona
Svetlana Vorona
SSStanislav Selivanov
Stanislav Selivanov
VTVyacheslav Tribulovich
Vyacheslav Tribulovich
Tetrahydropyrazolo[1,5-a]pyrimidine (THPP) is an attractive scaffold for designing biologically active compounds. The most obvious way to obtain such compounds is to reduce pyrazolopyrimidines with complex hydrides, because the pyrimidine ring is reduced in the preference over the pyrazole ring. The presence of substituents at positions five and seven of pyrazolo[1,5-a]pyrimidines complicates the set of reaction products but makes it more attractive for medicinal chemistry because four possible stereoisomers can be formed during reduction. However, the formation of only syn-isomers has been described in the literature. This article is the first report on the formation of anti-configured isomers along with syn-isomers in the reduction of model 5,7-dimethylpyrazolo[1,5-a]pyrimidine, which was confirmed by NMR. The bicyclic core in the syn-configuration was shown to be conformationally stable, which was used to estimate the long-range interproton distances using NOESY data. At the same time, long-range dipole–dipole interactions corresponding to a distance between protons of more than 6 Å were first registered and quantified. In turn, the bicyclic core in the trans-configuration represents a conformationally labile system. For these structures, an analysis of conformations observed in solutions was carried out. Our results indicate the significant potential of trans-configured tetrahydropyrazolo[1,5-a]pyrimidines for the development of active small molecules. While possessing structural lability due to the low energy of the conformational transition, they have the ability to adjust to the active site of the desired target.

28 November 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
TGTatyana Grigoreva
Tatyana Grigoreva
ASAleksandra Sagaidak
Aleksandra Sagaidak
Svetlana VoronaSvetlana Vorona
Svetlana Vorona
DNDaria Novikova
Daria Novikova
VTVyacheslav Tribulovich
Vyacheslav Tribulovich

22 May 2025 in Molecules
Verified
Journal Article
Open access
PDF file
DNDaria Novikova
Daria Novikova
Svetlana VoronaSvetlana Vorona
Svetlana Vorona
AZAnastasiya Zenina
Anastasiya Zenina
TGTatyana Grigoreva
Tatyana Grigoreva
VTVyacheslav Tribulovich
Vyacheslav Tribulovich
Pyrazolo[1,5-a]pyrimidine is a nitrogen-containing fused heterocycle that imitates the nitrogenous base adenine with varying degrees of reliability. This fact determines its frequent use in drug design, including the development of ATP-competitive kinase inhibitors. These include dorsomorphin which shows compromised kinase selectivity but is still widely used as an AMPK inhibitor. ATP-binding pockets of many proteins have a fairly conservative spatial structure and there is a high probability of obtaining a compound with low target selectivity during drug development. In the case of a common scaffold, the careful selection of side substituents that determine the activity and selectivity of the final compound plays an important role. In this work, a convergent strategy for the synthesis of dorsomorphin and its close analogs was developed and implemented. The resulting small series of compounds is distinguished by the maximum possible diversification and allows for an assessment of the biological activity towards AMPK. An original route to obtain variants of the phenoxy-alkylamine moiety of dorsomorphin via the Mitsunobu reaction will be useful for generating targeted-focused libraries of ATP-competitive kinase inhibitors and highly active receptor ligands.

16 July 2024 in ACS Omega
Verified
Journal Article
Open access
TGTatyana Grigoreva
Tatyana Grigoreva
Svetlana VoronaSvetlana Vorona
Svetlana Vorona
DNDaria Novikova
Daria Novikova
VTVyacheslav Tribulovich
Vyacheslav Tribulovich
The use of viral protein inhibitors has shown to be insufficiently effective in the case of highly variable SARS-CoV-2. In this work, we examined the possibility of designing agents that bind to a highly conserved region of coronavirus (+)RNA. We demonstrated that while the design of antisense RNAs is based on the complementary interaction of nitrogenous bases, it is possible to use semirigid docking methods in the case of unnatural peptide nucleic acids. The transition from N-(2-aminoethyl)glycine chain to a more conformationally rigid piperidine-containing backbone allowed us to significantly increase the affinity of structures to the target RNA.